A brand new examine from researchers highlights an surprising participant in Alzheimer’s illness: growing old astrocytes.
Senescent astrocytes have been recognized as a serious contributor to Alzheimer’s development. The cells lose protecting features and gasoline irritation, significantly in APOE4 carriers. The findings spotlight senolytic medicine as a possible new remedy.
For the primary time, the analysis staff has proven that senescent astrocytes are current within the brains of individuals with Alzheimer’s illness. These cells stay alive however have misplaced their regular perform, and their accumulation means that mobile growing old performs a direct and vital position in neurodegeneration.
The findings have been revealed within the Journal of Neuroinflammation. The examine was led by Dr. Antonia Gutiérrez, Professor of Cell Biology and Principal Investigator of the NeuroAD group, alongside Dr. Juan Antonio García León, Affiliate Professor of Cell Biology. The analysis staff additionally included Laura Cáceres, Laura Trujillo, Elba López, Elisabeth Sánchez, and Inés Moreno.
Astrocytes are the commonest kind of glial cell within the mind. They’re important for sustaining wholesome neurons and supporting correct mind perform. Nevertheless, the researchers discovered that in people with the strongest genetic danger issue for Alzheimer’s illness (APOE4), astrocytes present indicators of irregular early growing old.
APOE4 Genotype Drives Untimely Astrocyte Getting old
“We’ve confirmed that these broken astrocytes not solely lose their capacity to guard neurons but in addition undertake a pro-inflammatory profile that severely compromises neuronal survival,” the authors clarify. Upon coming into a state of senescence, the cells accumulate DNA injury, exhibit mitochondrial alterations—the mobile ‘powerhouses’—and ‘launch poisonous molecules that amplify irritation and tissue injury within the mind.
To research these processes, the scientists used induced pluripotent stem cells (iPSCs). By taking small pores and skin samples from sufferers, they have been capable of reprogram the cells within the laboratory and generate useful human astrocytes for detailed examine.
This strategy allowed the staff to look at illness mechanisms immediately in human cells, avoiding a number of the limitations of animal fashions, which don’t all the time seize the total complexity of the human mind.
Human Validation Confirms Central Function in Neurodegeneration
The laboratory findings have been strengthened by analyzing mind tissue obtained after demise from people with Alzheimer’s illness. The evaluation strongly instructed that almost 80 % of the cells within the cerebral cortex that displayed indicators of untimely growing old have been astrocytes. This proportion was a lot greater than what’s seen in wholesome individuals of the identical age.
Collectively, these outcomes help the concept that astrocyte senescence will not be merely a byproduct of the illness however a driving pressure behind its development.
The invention is particularly necessary given that there’s presently no efficient remedy able to curing Alzheimer’s illness or stopping its advance. In Spain alone, greater than 1.2 million individuals are affected.
The findings counsel a brand new therapeutic course centered on growing revolutionary methods comparable to senolytic medicine. These remedies would goal to get rid of or “reprogram” aged astrocytes, with the objective of preserving neurons and slowing cognitive decline.
Reference: “Human iPSC-derived APOE4/4 Alzheimer´s illness astrocytes exhibit a senescent and pro-inflammatory state that compromises neuronal help” by Laura Caceres-Palomo, Elisabeth Sanchez-Mejias, Laura Trujillo-Estrada, Juan Jose Perez-Moreno, Elba Lopez-Oliva, Tau En Lim, Leah DeFlitch, Serena H. Chang, Lucas Kampman, M. Ryan Corces, Mathew Blurton-Jones, Ines Moreno-Gonzalez, Alberto Pascual, Javier Vitorica, Juan Antonio Garcia-Leon and Antonia Gutierrez, 12 December 2025, Journal of Neuroinflammation.
DOI: 10.1186/s12974-025-03607-z
